D-Index & Metrics Best Publications

Laurent Lagrost

Grenoble Alpes University
France

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Biology and Biochemistry D-index 54 Citations 8,163 207 World Ranking 11231 National Ranking 408

Overview

What is he best known for?

The fields of study Laurent Lagrost is best known for:

Cholesterol
Lipoprotein
Phospholipid

Laurent Lagrost combines Cholesterol and Low-density lipoprotein in his research. His research on Low-density lipoprotein frequently links to adjacent areas such as Endocrinology. In most of his Endocrinology studies, his work intersects topics such as Cholesteryl ester. His work often combines Cholesteryl ester and Very low-density lipoprotein studies. Laurent Lagrost connects Very low-density lipoprotein with Intermediate-density lipoprotein in his study. Laurent Lagrost conducts interdisciplinary study in the fields of Intermediate-density lipoprotein and Cholesterol through his research. His work often combines Lipoprotein and Sterol O-acyltransferase studies. In his work, Laurent Lagrost performs multidisciplinary research in Sterol O-acyltransferase and Apolipoprotein B. He combines Apolipoprotein B and Lipoprotein in his studies.

His most cited work include:

Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. (110 citations)
Inhibitors of Arterial Relaxation Among Components of Human Oxidized Low-Density Lipoproteins (81 citations)
Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. (76 citations)

What are the main themes of his work throughout his whole career to date

Laurent Lagrost undertakes multidisciplinary investigations into Cholesterol and LDL receptor in his work. He merges many fields, such as LDL receptor and Lipoprotein, in his writings. He performs integrative Lipoprotein and Low-density lipoprotein research in his work. His work on Low-density lipoprotein is being expanded to include thematically relevant topics such as Internal medicine. His research ties Adipose tissue and Internal medicine together. While working on this project, he studies both Adipose tissue and Cholesterol. Laurent Lagrost incorporates Biochemistry and Gel electrophoresis in his research. In his articles, he combines various disciplines, including Apolipoprotein B and Triglyceride. Laurent Lagrost integrates Triglyceride and Apolipoprotein B in his studies.

Laurent Lagrost most often published in these fields:

Cholesterol (94.74%)
Biochemistry (89.47%)
Lipoprotein (89.47%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies

Laurent Lagrost.
Biochimica et Biophysica Acta (1994)

261 Citations

Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte.

Emmanuelle Reboul;Alexis Klein;Florence Bietrix;Béatrice Gleize.
Journal of Biological Chemistry (2006)

258 Citations

Characterization and Comparison of the Mode of Cell Death, Apoptosis Versus Necrosis, Induced by 7β-Hydroxycholesterol and 7-Ketocholesterol in the Cells of the Vascular Wall

Gérard Lizard;Serge Monier;Catherine Cordelet;Laurence Gesquière.
Arteriosclerosis, Thrombosis, and Vascular Biology (1999)

235 Citations

Induction of apoptosis in endothelial cells treated with cholesterol oxides.

G Lizard;V Deckert;L Dubrez;M Moisant.
American Journal of Pathology (1996)

184 Citations

Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy.

Anne-Laure Rérole;Jessica Gobbo;Aurelie De Thonel;Elise Schmitt.
Cancer Research (2011)

165 Citations

Human Apolipoprotein C-I Accounts for the Ability of Plasma High Density Lipoproteins to Inhibit the Cholesteryl Ester Transfer Protein Activity

Thomas Gautier;David Masson;Jean-Paul Pais de Barros;Anne Athias.
Journal of Biological Chemistry (2000)

163 Citations

The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis.

David Masson;David Masson;Xian-Cheng Jiang;Laurent Lagrost;Alan R. Tall.
Journal of Lipid Research (2009)

160 Citations

Opposite Effects of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein on the Size Distribution of Plasma High Density Lipoproteins PHYSIOLOGICAL RELEVANCE IN ALCOHOLIC PATIENTS

Laurent Lagrost;Anne Athias;Bernard Herbeth;Valérie Guyard-Dangremont.
Journal of Biological Chemistry (1996)

153 Citations

Variation at the apo AI/CIII/A1V gene complex is associated with elevated plasma levels of apo CIII

C.C. Shoulders;P.J. Harry;L. Lagrost;S.E. White.
Atherosclerosis (1991)

150 Citations

PHOSPHOLIPID AND CHOLESTERYL ESTER TRANSFER ACTIVITIES IN PLASMA FROM 14 VERTEBRATE SPECIES. RELATION TO ATHEROGENESIS SUSCEPTIBILITY

Valérie Guyard-Dangremont;Catherine Desrumaux;Philippe Gambert;Christian Lallemant.
Comparative Biochemistry and Physiology B (1998)

150 Citations

If you think any of the details on this page are incorrect, let us know.